PDF icon PDF herunterladen
Semin Reprod Med 2017; 35(03): 231-240
DOI: 10.1055/s-0037-1603571
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Ovary as a Biomarker of Health and Longevity: Insights from Genetics

Aleksandar Rajkovic
1   Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
2   Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania
3   Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania
5   Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas
,
Stephanie Pangas
5   Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas
6   Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
28. Juni 2017 (online)

   Lizenzen und Reprints
Preview

Abstract

Reproductive fitness and its influence on overall health has been a topic of significant study and interest. Multiple studies have found that age at last reproduction associates with overall health. Women who conceive later in life are significantly more likely to outlive their peers who are unable to conceive. The mechanisms behind these observations are not well understood. Earlier age at menopause associates with shorter life span, increased risk for diabetes mellitus, and increased risk of heart disease, and represents a surrogate marker for the age at last reproduction. Recent applications of genome-wide association studies as well as whole-exome sequencing to familial primary ovarian insufficiency (POI) and menopause have identified new genomic regions that link reproductive aging and adverse health outcomes. The preponderance of DNA damage response genes in menopause and POI represents a relatively new paradigm in this area, and links overall aging and reproduction at the molecular level. Identification of the subset of individuals who are at risk for adverse health outcomes remains a significant and high priority research challenge. The combination of epidemiologic studies in women with diminished ovarian reserves, ovarian insufficiency, and early menopause, as well as appropriate animal studies, will be necessary to dissect genotype–phenotype correlations not only in the cause of ovarian dysfunction but also in the cause of adverse health outcomes.

Keywords

ovarian reserve - menopause - primary ovarian insufficiency - DNA damage response genes